Cardiff Oncology(DE:XE7C)
€0.64-0.01 (-1.69%)
DE:XE7C
Cardiff Oncology earnings date
€0.64
At close:-0.01 (-1.69%)
Cardiff Oncology (XE7C) Q4 2022 Earnings Report
3 Followers
DE:XE7C Q4 2022 EPS Results
- Actual EPS
- -EUR 0.18
- Consensus EPS
- -EUR 0.21
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- -EUR 0.21
DE:XE7C Q4 2022 Revenue Results
- Actual Revenue
- EUR 115.70K
- Expected Revenue
- EUR 65.99K
- Beat/Miss
- Beat by +EUR 49.72K
- YoY Revenue Growth
- -3.76%
Earnings Announcement Details
- Quarter
- Q4 2022
- Date
- 03/02/2023
- Time
- After Close
- Conference Call
- Thursday, March 2, 2023
DE:XE7C Upcoming Earnings
Cardiff Oncology's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q4 2022 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2022 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2022 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:XE7C Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | -0.12- | -0.1 | ― | ― |
| Nov 12, 2026 | 2026 (Q3) | -0.12-0.11 | -0.15 | 29.41% (+0.05) | |
| Aug 11, 2026 | 2026 (Q2) | -0.11-0.13 | -0.19 | 33.33% (+0.06) | |
| May 14, 2026 | 2026 (Q1) | -0.12-0.16 | -0.18 | 10.00% (+0.02) | |
| Feb 24, 2026 | 2025 (Q4) | -0.17-0.10 | -0.2 | 50.00% (+0.10) | |
| Nov 06, 2025 | 2025 (Q3) | -0.19-0.15 | -0.23 | 32.00% (+0.07) | |
| Jul 29, 2025 | 2025 (Q2) | -0.17-0.19 | -0.24 | 19.23% (+0.05) | |
| May 08, 2025 | 2025 (Q1) | -0.17-0.18 | -0.2 | 9.09% (+0.02) | |
| Feb 27, 2025 | 2024 (Q4) | -0.22-0.20 | -0.19 | -4.76% (-0.01) | |
| Nov 07, 2024 | 2024 (Q3) | -0.24-0.23 | -0.2 | -13.64% (-0.03) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
